Transactions

Case Study

Avanti Polar Lipids
Industries:
Healthcare
Description:
Avanti Polar Lipids is a leader in the development and manufacturing of high-purity lipids and associated pharmaceutical services that are utilized as drug delivery solutions for complex therapeutic drugs and next generation mRNA vaccines. The Company operates from its campus in Alabama with its skilled workforce of approximately 150 employees, including over 100 scientists. Throughout Avanti's history, the Company has been an innovator in lipid-based products and applications for the life sciences markets and currently serves thousands of leading biopharmaceutical companies and researchers around the world. The Company has two primary revenue streams in research products and pharmaceutical services. Since the Company's founding it has been a leader in developing lipids for life science research and currently offers over 2,000 lipid and adjuvant products. The Company also offers pharmaceutical services where it leverages its lipid based expertise to develop and supply drug delivery solutions for complex therapeutics. Avanti provides a comprehensive range of services from formulation and analytical services through cGMP manufacturing of synthetic lipids and adjuvants for clinical and commercial applications.
Location:
Alabaster, AL
Ownership:
Private
Transaction Type:
Sellside Advisory

Situation

BlackArch was retained by Avanti to serve as its exclusive financial advisor.

BlackArch's Customized Solution

The transaction continues BlackArch’s significant momentum in the pharmaceutical services and healthcare sectors and is representative of the firm’s focus on providing dedicated M&A advisory services to market-leading businesses.

Outcome

Avanti has agreed to be acquired by Croda International Plc. Avanti's know-how and technologies are highly complementary to Croda's capabilities in drug delivery systems, vaccine adjuvants and immunotherapy. Avanti will be able to combine its leading position in pharmaceutical lipid-based applications with Croda's access to global markets, greater manufacturing capacity and a broader set of capabilities to expand the range of products and services for the combined customer base.